Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Gerstner

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Antibodies (Basel, Switzerland)|November 21, 2023
The Role of Antibody-Based Therapies in Neuro-OncologyRishab Ramapriyan, Jing Sun, Annabel Curry, et al.
Neuroinformatics|January 22, 2018
Field of View Normalization in Multi-Site Brain MRIYangming Ou, Lilla Zöllei, Xiao Da, et al.
Tomography (Ann Arbor, Mich.)|January 28, 2017
Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) SurveyBrenda F Kurland, Sameer Aggarwal, Thomas E Yankeelov, et al.
Neuroinformatics|June 25, 2020
DeepNeuro: an open-source deep learning toolbox for neuroimagingAndrew Beers, James Brown, Ken Chang, et al.
Nature Reviews. Clinical Oncology|April 1, 2009
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancerElizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Journal of Neuro-Oncology|September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideElizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.
Interface Focus|October 7, 2016
Multimodality imaging and mathematical modelling of drug delivery to glioblastomasAhmed Boujelben, Michael Watson, Steven McDougall, et al.
The New England Journal of Medicine|March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaBryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Antibodies (Basel, Switzerland)|November 21, 2023
The Role of Antibody-Based Therapies in Neuro-OncologyRishab Ramapriyan, Jing Sun, Annabel Curry, et al.
Neuroinformatics|January 22, 2018
Field of View Normalization in Multi-Site Brain MRIYangming Ou, Lilla Zöllei, Xiao Da, et al.
Tomography (Ann Arbor, Mich.)|January 28, 2017
Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) SurveyBrenda F Kurland, Sameer Aggarwal, Thomas E Yankeelov, et al.
Neuroinformatics|June 25, 2020
DeepNeuro: an open-source deep learning toolbox for neuroimagingAndrew Beers, James Brown, Ken Chang, et al.
Nature Reviews. Clinical Oncology|April 1, 2009
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancerElizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Journal of Neuro-Oncology|September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideElizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.
Interface Focus|October 7, 2016
Multimodality imaging and mathematical modelling of drug delivery to glioblastomasAhmed Boujelben, Michael Watson, Steven McDougall, et al.
The New England Journal of Medicine|March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaBryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Pageof 14